SLC2A1 and cancer: Elevated glucose metabolism, hypoxia-induced GLUT, LDH-A, and PFKFB3 overexpression, and the AKT- and c-Myc-mediated transcriptional activation of HK2 are observed in most cancer cells, and these metabolic changes may be exploited for developing effective therapeutic approaches.